Хайлтын үр дүнгүүд - Santos Carvajal‐Gonzalez
- 5-н 1 - 5 үр дүнгүүдийг харуулж байна
-
1
Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects -н William S. Denney, Gabriele E. Sonnenberg, Santos Carvajal‐Gonzalez, Theresa Tuthill, V. Margaret Jackson
Хэвлэсэн 2016Artigo -
2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study -н Arthur Bergman, Santos Carvajal‐Gonzalez, Sanela Tarabar, Aditi R. Saxena, William P. Esler, Neeta B. Amin
Хэвлэсэн 2020Artigo -
3
-
4
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems -н Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal‐Gonzalez, Magalie Boucher, Dinesh Hirenallur‐Shanthappa, Jeffrey Morin, Alan Opsahl, Sarah Regina Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler
Хэвлэсэн 2020Artigo -
5
Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes -н David A. Griffith, Daniel W. Kung, William P. Esler, Paul A. Amor, Scott W. Bagley, Carine Beysen, Santos Carvajal‐Gonzalez, Shawn D. Doran, Chris Limberakis, Alan M. Mathiowetz, Kirk McPherson, David A. Price, Éric Ravussin, Gabriele E. Sonnenberg, James A. Southers, Laurel J. Sweet, Scott Turner, F.F. Vajdos
Хэвлэсэн 2014Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Chemistry
Internal medicine
Biochemistry
Biology
Enzyme
Insulin
Pharmacology
Acetyl-CoA carboxylase
Adverse effect
Beta oxidation
Disease
Endocrinology
Fatty liver
Lipogenesis
Metabolism
Nonalcoholic fatty liver disease
Pharmacodynamics
Pharmacokinetics
Postprandial
Pyruvate carboxylase
Steatohepatitis
Steatosis
Tolerability
Agonist
Alternative medicine
Biotechnology
Diacylglycerol kinase
Fibrosis
Gastric emptying